✦ LIBER ✦

Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy

✍ Scribed by Shamir R. Mehta; Jean-Pierre Bassand; Susan Chrolavicius; Rafael Diaz; Keith A.A. Fox; Christopher B. Granger; Sanjit Jolly; Hans-Jurgen Rupprecht; Petr Widimsky; Salim Yusuf

Book ID: 116191554
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 361 KB
Volume: 156
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2008.07.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and rationale of the Treatment of

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

✍ Philippe Gabriel Steg; Shamir R. Mehta; Charles V. Pollack Jr.; Christoph Bode; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Design and rationale of the MICHELANGELO

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Study design and rationale of a comparis

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

✍ Chee Tang Chin; Matthew T. Roe; Keith A.A. Fox; Dorairaj Prabhakaran; Debra A. M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 311 KB